These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study. Botticella A; Defraene G; Nackaerts K; Deroose CM; Coolen J; Nafteux P; Peeters S; Ricardi U; De Ruysscher D Acta Oncol; 2016 Dec; 55(12):1450-1455. PubMed ID: 27732127 [TBL] [Abstract][Full Text] [Related]
12. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer. Bassi MC; Turri L; Sacchetti G; Loi G; Cannillo B; La Mattina P; Brambilla M; Inglese E; Krengli M Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1423-6. PubMed ID: 17931795 [TBL] [Abstract][Full Text] [Related]
13. FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma. Krengli M; Milia ME; Turri L; Mones E; Bassi MC; Cannillo B; Deantonio L; Sacchetti G; Brambilla M; Inglese E Radiat Oncol; 2010 Feb; 5():10. PubMed ID: 20137093 [TBL] [Abstract][Full Text] [Related]
14. Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma. Pilling J; Dartnell JA; Lang-Lazdunski L Thorac Cardiovasc Surg; 2010 Jun; 58(4):215-9. PubMed ID: 20514576 [TBL] [Abstract][Full Text] [Related]
15. Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison. Piroth MD; Pinkawa M; Holy R; Stoffels G; Demirel C; Attieh C; Kaiser HJ; Langen KJ; Eble MJ Radiat Oncol; 2009 Nov; 4():57. PubMed ID: 19930657 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results. Guerra L; Meregalli S; Zorz A; Niespolo R; De Ponti E; Elisei F; Morzenti S; Brenna S; Crespi A; Gardani G; Messa C Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):702-10. PubMed ID: 24177810 [TBL] [Abstract][Full Text] [Related]
17. Additional value of hybrid PET/CT fusion imaging vs. conventional CT scan alone in the staging and management of patients with malignant pleural mesothelioma. Ambrosini V; Rubello D; Nanni C; Farsad M; Castellucci P; Franchi R; Fabbri M; Rampin L; Crepaldi G; Al-Nahhas A; Fanti S Nucl Med Rev Cent East Eur; 2005; 8(2):111-5. PubMed ID: 16437396 [TBL] [Abstract][Full Text] [Related]
18. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma? Sharif S; Zahid I; Routledge T; Scarci M Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493 [TBL] [Abstract][Full Text] [Related]
19. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study. Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122 [TBL] [Abstract][Full Text] [Related]
20. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging. Ohno Y; Yui M; Aoyagi K; Kishida Y; Seki S; Koyama H; Yoshikawa T AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]